Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022–2023Duygu İşlek, Vani Vannappagari, Danielle Friedman Nestadt et al.|PLoS ONE|2025Cited by 3
HIV Preexposure Prophylaxis Utilization and Reasons for Never Using Preexposure Prophylaxis Among Transfeminine Persons in the United States: Findings From the Transgender Women’s Internet Survey and Testing (TWIST) StudyDuygu Islek, Vani Vannappagari, Travis Sanchez et al.|Open Forum Infectious Diseases|2026Cited by 1
Characteristics Associated With the HIV Preexposure Prophylaxis Care Continuum Among Transfeminine Persons in the United StatesDuygu İşlek, Vani Vannappagari, Savannah Winter et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2025Cited by 0